Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/22516
Başlık: Sella turcica metastasis from follicular carcinoma of thyroid
Yazarlar: Uludağ Üniversitesi/Tıp Fakültesi/Beyin ve Sinir Cerrahisi Anabilim Dalı.
0000-0003-3633-7919
Yılmazlar, Selçuk
Kocaeli, Hasan
Cordan, Teoman
AAH-5070-2021
6603059483
6603500567
7801648865
Anahtar kelimeler: Lodine-131
Sella turcica
Thyroid carcinoma
Cancer-patients
Papillary carcinoma
Distant metastases
I-131 therapy
Pituitary
Thyroglobulin
Radioiodine
Metastasis
Neurosciences & neurology
Thyrogen
Yayın Tarihi: Oca-2004
Yayıncı: Taylor & Francis
Atıf: Yılmazlar, S. vd. (2004). “Sella turcica metastasis from follicular carcinoma of thyroid”. Neurological Research, 26(1), 74-78.
Özet: A case of metastasis to the sella turcica from a follicular adenocarcinoma of the thyroid gland is presented. Metastasis to this site is rare and review of the literature reveals only 12 cases of metastatic thyroid carcinoma involving the sella turcica and pituitary gland. The optimal treatment strategy is still to be determined. A 43-year-old woman presented with headache, nausea, visual impairment and galactorrhea. An MRI scan of the cranium revealed an enhancing destructive sellar lesion. The patient underwent transsphenoidal removal of the lesion to alleviate visual loss. The histological features of the sellar tumor were identical to those of a follicular adenocarcinoma partially removed from the thyroid gland 22 months earlier. Total thyroidectomy followed by three courses of iodine-131 ablation enhanced with synthetic thyrotropin and thyroid hormone suppression therapy was instituted. The post-operative course was satisfactory with improved vision and ceased galactorrhea. This case was successfully treated with a combination of surgical removal, iodine-131 ablation and hormone suppression therapy, which resulted in disease control duration of four years. Sella turcica metastases of thyroid carcinoma are exceedingly rare and currently there are no established therapeutic guidelines.
URI: https://doi.org/10.1179/016164104773026561
https://www.tandfonline.com/doi/abs/10.1179/016164104773026561
http://hdl.handle.net/11452/22516
ISSN: 0161-6412
1743-1328
Koleksiyonlarda Görünür:Scopus
Web of Science

Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.


DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.